Novo Nordisk gets FDA fast track status for ATTR heart disease drug
Go back to Novo Nordisk gets FDA fast track status for ATTR heart disease drug| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 45.88 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $45.88 | 52 Week High | $59.00 | |||
| Open | $45.88 | 52 Week Low | $32.80 | |||
| Day High | $45.88 | P/E | N/A | |||
| Day Low | $45.88 | EPS | $0.00 | |||
| Volume | 214,558 | |||||
| PROTHENA CORP (NASDAQ: PRTA) | Delayed: 9.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.15 | 52 Week High | $76.42 | |||
| Open | $9.15 | 52 Week Low | $28.20 | |||
| Day High | $9.15 | P/E | N/A | |||
| Day Low | $9.15 | EPS | $-2.84 | |||
| Volume | 9 | |||||

